Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back
programme for Nordhealth AS ("Nordhealth") (Ticker: NORDH NO).

Date on which the share buy-back programme was announced: 5 June 2023.

The duration of the buy-back programme: 5 June 2023 until no later than 31
December 2023 or the maximum share size or consideration has been reached.

Size of the buy-back programme: Up to 400,000 shares, for a maximum
consideration of NOK 4,000,000.

From 14 June 2023 until 22 June 2023, Nordhealth has purchased a total of 97,335
own shares at an average price of NOK 26.1525 per share.

Aggregated overview of transactions per day:

Date                             Aggregate daily       Weighted         Total
                                    volume (# of  average price   transaction
                                         shares)          (NOK)   value (NOK)
14.06.2023                                12,754        23.8468    304,141.90
15.06.2023                                20,063        24.9133    499,836.50
16.06.2023                                20,389        27.8926    568,703.20
19.06.2023                                 5,107        26.9321    137,542.40
20.06.2023                                18,076        27.3548    494,466.20
21.06.2023                                 8,455        25.5257    215,820.20
22.06.2023                                12,491        26.0220    325,040.70

Previously disclosed buy-backs            20,878        23.2015    484,401.84
under the programme (aggregate)
Total purchased under the                118,213        25.6313  3,029,952.94
programme

This information is published in accordance with the requirements in article 5
of the EU Market Abuse Regulation and subject to the disclosure requirements
pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back
programme that have been carried out during the above-mentioned time period is
attached to this report.

For further information, please contact:

Mari Orttenvuori, CFO

[e-mail]

[phone]

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com/).

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange